88 related articles for article (PubMed ID: 8526179)
41. IgG1, IgG4 and IgE antibody reactivity to mutant forms of the major dust mite allergen Lep d 2 among atopic and nonatopic subjects naturally exposed to Lepidoglyphus destructor.
Olsson S; van Hage-Hamsten M; Magnusson CG
Int Arch Allergy Immunol; 2001 Sep; 126(1):50-8. PubMed ID: 11641606
[TBL] [Abstract][Full Text] [Related]
42. Expression of two isoforms of Lep d 2, the major allergen of Lepidoglyphus destructor, in both prokaryotic and eukaryotic systems.
Olsson S; van Hage-Hamsten M; Whitley P; Johansson E; Hoffman DR; Gafvelin G; Schmidt M
Clin Exp Allergy; 1998 Aug; 28(8):984-91. PubMed ID: 9756203
[TBL] [Abstract][Full Text] [Related]
43. Clinical experience with specific immunotherapy to horse dander.
Fernández-Távora L; Rico P; Martín S
J Investig Allergol Clin Immunol; 2002; 12(1):29-33. PubMed ID: 12109529
[TBL] [Abstract][Full Text] [Related]
44. Effects of immunotherapy with a purified standardized allergen preparation of Dermatophagoides farinae in adults with perennial allergic rhinoconjunctivitis.
Löfkvist T; Agrell B; Dreborg S; Svensson G
Allergy; 1994 Feb; 49(2):100-7. PubMed ID: 8172356
[TBL] [Abstract][Full Text] [Related]
45. Changes of house dust mite-specific IgE, IgG and IgG subclass antibodies during immunotherapy in patients with perennial rhinitis.
Nakagawa T; Kozeki H; Katagiri J; Fujita Y; Yamashita N; Miyamoto T; Skvaril F
Int Arch Allergy Appl Immunol; 1987; 82(1):95-9. PubMed ID: 3804457
[TBL] [Abstract][Full Text] [Related]
46. [The reflexotherapy of patients with respiratory allergoses].
Nezabudkin SN; Kachan AT; Fedoseev GB; Gamaiunov KP
Ter Arkh; 1992; 64(1):64-7. PubMed ID: 1523566
[TBL] [Abstract][Full Text] [Related]
47. Allergen immunotherapy.
Rank MA; Li JT
Mayo Clin Proc; 2007 Sep; 82(9):1119-23. PubMed ID: 17803880
[TBL] [Abstract][Full Text] [Related]
48. Allergen specific IgG subclass antibody response in hyposensitization with Dermatophagoides pteronyssinus extract.
Pastorello EA; Incorvaia C; Gerosa A; Vassellatti D; Italia M; Pravettoni V
N Engl Reg Allergy Proc; 1987; 8(6):417-21. PubMed ID: 3481429
[TBL] [Abstract][Full Text] [Related]
49. Effect of immunotherapy: treatment with mite and other aeroallergens in Thai allergic patients.
Choovoravech P
J Med Assoc Thai; 1980 Sep; 63(9):506-11. PubMed ID: 7420002
[No Abstract] [Full Text] [Related]
50. A double-blind study of hyposensitization with an alginate-conjugated extract of Dermatophagoides pteronyssinus (Conjuvac) in patients with perennial rhinitis. II. Immunological aspects.
Pastorello EA; Ortolani C; Incorvaia C; Farioli L; Italia M; Pravettoni V; Harris RJ; Watson HK; Corrado OJ; Davies RJ
Allergy; 1990 Oct; 45(7):505-14. PubMed ID: 2252161
[TBL] [Abstract][Full Text] [Related]
51. [Circulating immune complexes and anti-mite specific IgG antibody in status asthmatics--effects of methylprednisolone and analysis of an anti-complementary factor].
Onodera H; Takemura S; Kasamatsu Y; Seto N; Nakanishi S; Nakahara R; Ichio N; Ashihara K; Doi T; Yanagida K
Arerugi; 1993 Nov; 42(11):1650-6. PubMed ID: 8279965
[TBL] [Abstract][Full Text] [Related]
52. Immunotherapy with allergenic extracts in geriatric patients: evaluation of effectiveness and safety.
Armentia A; Fernández A; Tapias JA; Méndez J; de la Fuente R; Sánchez-Palla P; Sanchís E
Allergol Immunopathol (Madr); 1993; 21(5):193-6. PubMed ID: 8160564
[TBL] [Abstract][Full Text] [Related]
53. Significant correlation between symptom score and IgG4 antibody titer following long-term immunotherapy for perennial allergic rhinitis.
Ohashi Y; Nakai Y; Okamoto H; Ohno Y; Sakamoto H; Tanaka A; Kakinoki Y
Ann Otol Rhinol Laryngol; 1997 Jun; 106(6):483-9. PubMed ID: 9199608
[TBL] [Abstract][Full Text] [Related]
54. Blocking activity of mite-specific IgG antibodies studied by skin tests.
Pecquet C; Murrieta M; Michelen V; Leynadier F; Dry J; Allary M; Fabre G; Saint-Blancard J
Allergy; 1989 Aug; 44(6):427-31. PubMed ID: 2679220
[TBL] [Abstract][Full Text] [Related]
55. [Hyposensitization in the treatment of allergic conditions. Indications and clinical effects in allergic rhinoconjunctivitis].
Heinig JH; Malling HJ; Mosbech H; Weeke B
Ugeskr Laeger; 1987 Jun; 149(25):1663-6. PubMed ID: 3603851
[No Abstract] [Full Text] [Related]
56. [The clinical studies of 30 cases perennial allergic rhinitis with special immunotherapy].
Zhang H; Hua Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Apr; 21(8):356-8. PubMed ID: 17608155
[TBL] [Abstract][Full Text] [Related]
57. Myeloperoxidase release after allergen-specific conjunctival challenge.
Monteseirín J; Fernández-Pineda I; Chacón P; Vega A; Bonilla I; Camacho MJ; Fernández-Delgado L; Conde J; Sobrino F
J Asthma; 2004 Sep; 41(6):639-43. PubMed ID: 15584313
[TBL] [Abstract][Full Text] [Related]
58. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. II. In vitro results.
Karlsson R; Agrell B; Dreborg S; Foucard T; Kjellman NI; Koivikko A; Einarsson R
Allergy; 1986 Feb; 41(2):141-50. PubMed ID: 3518527
[TBL] [Abstract][Full Text] [Related]
59. Immunotherapy in allergic conjunctivitis.
Prakash OM; Murthy KR
Indian J Ophthalmol; 1992; 40(1):9-10. PubMed ID: 1464456
[TBL] [Abstract][Full Text] [Related]
60. IgG1 and IgG4 antibody responses to the dust mite Lepidoglyphus destructor in a naturally exposed farming population.
Johansson E; Härfast B; Johansson SG; van Hage-Hamsten M
Allergy; 1995 Jun; 50(6):473-7. PubMed ID: 7573839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
